Dong-A ST introduces a new antiviral with Japanese TAKARA BIO INC
Dong-A ST(CEO/President Dae-Shik Eom) announced on the 23rd that they signed an agreement to introduce a new antiviral with a Japanese biotechnology company TAKARA BIO INC(CEO Nakao Koichi), which develops gene and cell therapies, in Tokyo, Japan on the 22nd.
Under the agreement, Dong-A ST will ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
